# LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis

> **NCT02668692** · PHASE3 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 213 (actual)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** LEO 80185 gel
- **DRUG:** Dovobet ® ointment

## Key facts

- **NCT ID:** NCT02668692
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 213 (ACTUAL)
- **Last updated:** 2025-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02668692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02668692, "LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02668692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*